Motus Files Pure-Vu Version US Application For Use During Upper GI Endoscopy

Motus GI Holdings Inc (NASDAQ: MOTS) has submitted a 510(k) application to the FDA for a version of the Pure-Vu System.
The new version of the system is compatible with gastroscopes used during upper gastrointestinal (GI) endoscopy procedures to remove blood, blood clots, and debris to provide a clear field-of-view for the endoscopist.
Price Action: MOTS shares are down 2.45% at $1.20 on the last check Tuesday.